Document is current
Any future updates will be listed below
-
Authors
Mohiuddin, Syed G.
Ward, Mary E. https://orcid.org/0000-0002-2321-2546
Hollingworth, William
Watson, Jessica C.
Whiting, Penny F.
Thom, Howard H. Z.
-
Funding
Funding for this research was provided by:
Programme Grants for Applied Research (NIHR201616)
Medical Research Council (MR/S036709/1, MR/W029855/1)
- License Information
-
More Information
Article History
Accepted: 24 January 2024
First Online: 23 February 2024
Declarations
:
: WH, HT and SM developed the study concept and design. SM drafted the study protocol and designed the search strategies in conjunction with WH and HT; SM conducted the electronic searches. SM, HT and WH independently screened and appraised the relevant studies and extracted the data from the included studies. MW conducted additional screening and extractions. SM, HT, and MW drafted the manuscript. All authors commented on the draft and read and approved the submitted manuscript.
: This study was supported by National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research (NIHR201616). HT received funding from UK Medical Research Council Grants MR/S036709/1 and MR/W029855/1.
: Howard Thom owns shares in Clifton Insight, which has received funding from Roche, Pfizer, Bayer, Eisai, Lundbeck, Argenx, Novartis, and Merck, none of which were involved in this study. Syed Mohiuddin, Mary Ward, William Hollingworth, Jessica Watson, Penny Whiting, and Howard Thom have no conflicts of interest to declare.
: The data that support the findings of this study are available within this paper.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
